Abhisek Mukherjee
Papers
1
Total Citations
3
H-Index
1
About
Abhisek Mukherjee is a researcher whose work centers on the development of innovative biochemical assays to address critical challenges in neurodegenerative disease therapeutics. His primary research interests lie in protein misfolding disorders, particularly Alzheimer’s and Parkinson’s disease, and the discovery of small-molecule inhibitors that can disrupt pathological aggregation pathways. Mukherjee’s most notable contribution is the design of a fluorescent quenching-based high-throughput assay to screen for calcineurin inhibitors, a method that enables rapid, sensitive detection of potential therapeutic compounds. This work, published in 2015, has garnered 3 citations and represents a foundational tool for researchers seeking to identify new leads against protein misfolding. By focusing on the inhibition of aggregation—a key driver of neurodegeneration—Mukherjee’s assay addresses a pressing gap in treatment options, as no effective therapies currently exist for these devastating conditions. His approach exemplifies the integration of biophysical chemistry and drug discovery, offering a scalable platform for preclinical screening. Mukherjee’s research continues to inspire efforts toward translating mechanistic insights into viable clinical interventions.
Research Focus
Key Achievements
Top Papers
- 1